Lidocaine (topical) vs CYP3A4 Substrates

Interacting Drugs
Lidocaine (topical)
vs
CYP3A4 Substrates
Security Level
Minor, Monitor Therapy
Mechanism
CYP3A4 Substrates: CYP3A4 Inhibitors (Moderate) may decrease the metabolism of CYP3A4 Substrates.
Management
Monitor therapy

Subscribe for latest updates

Subscribe to our e-mail newsletter to receive updates.

No comments yet.

Post Review about Lidocaine (topical) vs CYP3A4 Substrates